Well, investors, NuVasive (NUVA) just couldn't wait to tell you the good news. Ahead of its presentation at the JPMorgan Healthcare Conference and its official Q4 earnings press release, the company revealed its full year 2012 revenue results. In this video, health care analyst Max Macaluso discusses why this news drove shares up by more than 10% and what investors should watch in 2013.